SHP2 and UGP2 are Biomarkers for Progression and Poor Prognosis of Gallbladder Cancer

Qunwei WangMinimally Invasive Surgery Center, Central South University, Changsha, China

Zhu-lin YangResearch Laboratory of Hepatobiliary Diseases, Second Xiangya Hospital, Central South University, Changsha, ChinaCorrespondence[email protected]

Qiong ZouDepartment of Pathology, Third Xiangya Hospital, Central South University, Changsha, China

Yuan YuanDepartment of Pathology, Third Xiangya Hospital, Central South University, Changsha, China

Jinghe LiDepartment of Pathology, Xiangya Hospital, Central South University, Changsha, China

Lufeng LiangDepartment of Hepatobiliary and Pancreatic Surgery, Hunan Provincial People's Hospital, Changsha, China

Guixiang ZengDepartment of Pathology, Loudi Central Hospital, Loudi, China

Senlin ChenDepartment of Pathology, Hunan Provincial Tumor Hospital, Changsha, China

show all

ABSTRACT

Biomarkers for the diagnosis, prognosis, and targeting therapy of gallbladder cancers are not clinically available. This study demonstrated that the percentage of cases with positive SHP2 and UGP2 expression significantly correlated with the percentage of cases with positive vimentin, β-catenin, MMP2, MMP9, and Ki-67 expression, large tumor size, high TNM stage, lymph node metastasis, and survival in patients with adenocarcinomas and squamous cell/adenosquamous carcinomas. Positive SHP2 and UGP2 expression are independent poor-prognostic factors in both types of tumors. Our study suggested that positive SHP2 and UGP2 expression correlated with clinicopathological and biological behaviors, and poor-prognosis of gallbladder cancer.

KEYWORDS:

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

SHP2 and UGP2 are Biomarkers for Progression and Poor Prognosis of Gallbladder Cancer

Information for

Open access

Opportunities

Help and information

SHP2 and UGP2 are Biomarkers for Progression and Poor Prognosis of Gallbladder Cancer

ABSTRACT

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature